Bladder Cancer Outcomes in Men vs. Women
Kyle A. Richards, MD, assistant professor, University of Wisconsin, discusses bladder cancer outcomes in men vs. women.
Richards mentions that women tend to have worse outcomes than men, but physicians do not yet have the information as to why. He and his colleagues predicted that women may not be evaluated as timely as men, which is ultimately what affects their outcomes.
Richards says primary care physicians now know to test patients for bladder cancer when there is blood in the urine. In order to conduct the study, Richards and his team organized patients by their symptom at presentation, in order to see whether their outcomes were worse, and then by male vs. female.
Kyle A. Richards, MD, assistant professor, University of Wisconsin, discusses bladder cancer outcomes in men vs. women.
FDA Accepts IND for UGN-103 in Low-Grade Intermediate-Risk NMIBC
April 15th 2024An investigational new drug application for UGN-103 was accepted by the FDA. A phase 3 study to assess the safety and efficacy of the agent in low-grade intermediate-risk non-muscle invasive bladder cancer is anticipated.
Read More
